BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28320591)

  • 1. Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
    Xu B; Zhu D; Bi Y; Wang Y; Hu Y; Zhou YH
    Vaccine; 2017 Apr; 35(18):2457-2462. PubMed ID: 28320591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.
    Caillat-Zucman S; Gimenez JJ; Wambergue F; Albouze G; Lebkiri B; Naret C; Moynot A; Jungers P; Bach JF
    Kidney Int; 1998 Jun; 53(6):1626-30. PubMed ID: 9607193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-DPA1, HLA-DPB1, and HLA-DQB1 Alleles With the Long-Term and Booster Immune Responses of Young Adults Vaccinated Against the Hepatitis B Virus as Neonates.
    Wang WC; Lin YS; Chang YF; Yeh CC; Su CT; Wu JS; Su FH
    Front Immunol; 2021; 12():710414. PubMed ID: 34484213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis.
    Li ZK; Nie JJ; Li J; Zhuang H
    Vaccine; 2013 Sep; 31(40):4355-61. PubMed ID: 23887040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine.
    Amirzargar AA; Mohseni N; Shokrgozar MA; Arjang Z; Ahmadi N; Yousefi Behzadi M; Amanzadeh A; Shokri F
    Iran J Immunol; 2008 Jun; 5(2):92-9. PubMed ID: 18523354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination.
    Lindemann M; Barsegian V; Siffert W; Ferencik S; Roggendorf M; Grosse-Wilde H
    Virology; 2002 Jun; 297(2):245-52. PubMed ID: 12083823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany.
    Anderson CL; Remschmidt C; Drobnitzky FP; Falkenhorst G; Zimmermann R; Wichmann O; Harder T
    Hum Vaccin Immunother; 2016 Mar; 12(3):779-84. PubMed ID: 26633195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity.
    Martinetti M; Cuccia M; Daielli C; Ambroselli F; Gatti C; Pizzochero C; Belloni C; Orsolini P; Salvaneschi L
    Vaccine; 1995 Apr; 13(6):555-60. PubMed ID: 7483776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term protection after hepatitis B vaccination in people living with HIV.
    Lara AN; Sartori AM; Fonseca MO; Lopes MH
    Vaccine; 2017 Jul; 35(33):4155-4161. PubMed ID: 28669615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
    Lin HH; Liao HW; Lin SK; Wang LY
    Vaccine; 2008 Jun; 26(27-28):3414-20. PubMed ID: 18501999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women.
    Ko SC; Schillie SF; Walker T; Veselsky SL; Nelson NP; Lazaroff J; Crowley S; Dusek C; Loggins K; Onye K; Fenlon N; Murphy TV
    Vaccine; 2014 Apr; 32(18):2127-33. PubMed ID: 24560676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients.
    Schuenke KW; Cook RG; Rich RR
    Hum Immunol; 1998 Dec; 59(12):783-93. PubMed ID: 9831134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients.
    Stachowski J; Kramer J; Füst G; Maciejewski J; Baldamus CA; Petrányi GG
    Scand J Immunol; 1995 Jul; 42(1):60-5. PubMed ID: 7631146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.